These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 9636480

  • 21. The early impact of mycophenolate mofetil in combination with steroids and cyclosporine Neoral after renal transplantation: a six-month analysis.
    Cubas A, Herrero JC, Morales E, Carreño A, Dominguez-Gil B, Cirujeda A, Praga M, Ortuño T, Hernandez E, Delgado M, Andres A, Morales JM.
    Transplant Proc; 1999 Sep; 31(6):2265-6. PubMed ID: 10500570
    [No Abstract] [Full Text] [Related]

  • 22. Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction.
    Senn B, Rochat P, Schwarzkopf AK, Weinreich T, Binswanger U.
    Transplant Proc; 1998 Dec; 30(8):4075-6. PubMed ID: 9865301
    [No Abstract] [Full Text] [Related]

  • 23. Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients.
    Kuypers DR, Evenepoel P, Maes BD, Coosemans W, Pirenne J, Vanrenterghem YF.
    Transplant Proc; 2002 Jun; 34(4):1164-70. PubMed ID: 12072305
    [No Abstract] [Full Text] [Related]

  • 24. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
    Hiesse C, Kriaa F, Eschwege P, Boubenider S, Marchand S, Benoit G, Charpentier B.
    Transplant Proc; 1999 Jun; 31(1-2):1111-2. PubMed ID: 10083496
    [No Abstract] [Full Text] [Related]

  • 25. Mycophenolate mofetil, ATG, and cyclosporine in the induction treatment of renal transplant recipients minimizes the incidence of acute rejection episodes.
    Puig JM, Lloveras J, Fernández-Crespo P, Mir M, Marcas LI, Manresa JM, Masramón J.
    Transplant Proc; 1998 Aug; 30(5):2226-7. PubMed ID: 9723449
    [No Abstract] [Full Text] [Related]

  • 26. A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.
    Fischer L, Sterneck M, Gahlemann CG, Malago M, Rogiers X, Broelsch CE.
    Transplant Proc; 2000 Nov; 32(7):2125-7. PubMed ID: 11120098
    [No Abstract] [Full Text] [Related]

  • 27. Mycophenolate mofetil/Neoral/steroid vs Neoral/steroid therapy for prophylaxis of acute rejection in renal transplant recipients.
    Carmellini M, Vistoli F, Bellini R, Boggi U, Rindi P, Rizzo G, Mosca F.
    Transplant Proc; 1999 Nov; 31(1-2):1162-4. PubMed ID: 10083519
    [No Abstract] [Full Text] [Related]

  • 28. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y.
    Transplantation; 2012 Feb 27; 93(4):437-43. PubMed ID: 22228415
    [Abstract] [Full Text] [Related]

  • 29. Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.
    Shaffer D, Madras PN, Conway P, Davis C, Simpson MA, Monaco AP.
    Transplant Proc; 1997 Feb 27; 29(1-2):342-3. PubMed ID: 9123031
    [No Abstract] [Full Text] [Related]

  • 30. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.
    Ettenger R, Cohen A, Nast C, Moulton L, Marik J, Gales B.
    Transplant Proc; 1997 Feb 27; 29(1-2):340-1. PubMed ID: 9123030
    [No Abstract] [Full Text] [Related]

  • 31. Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients.
    Suhail SM, Vathsala A, Lou HX, Woo KT.
    Transplant Proc; 2000 Nov 27; 32(7):1757-8. PubMed ID: 11119922
    [No Abstract] [Full Text] [Related]

  • 32. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 33. Results of renal transplantation with different immunosuppressive regimens.
    Folkmane I, Bicans J, Chapenko S, Murovska M, Rosentals R.
    Transplant Proc; 2002 Mar 27; 34(2):558-9. PubMed ID: 12009623
    [No Abstract] [Full Text] [Related]

  • 34. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.
    Smak Gregoor PJ, Hesse CJ, van Gelder T, van der Mast BJ, IJzermans JN, van Besouw NM, Weimar W.
    Transplant Proc; 1998 Jun 27; 30(4):1192-3. PubMed ID: 9636482
    [No Abstract] [Full Text] [Related]

  • 35. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report.
    Jurewicz WA.
    Transplant Proc; 1999 Nov 27; 31(7A):64S-66S. PubMed ID: 10576048
    [No Abstract] [Full Text] [Related]

  • 36. Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.
    Weber M, Deng S, Arenas J, Aradhye S, Grossman R, Shaw L, Naji A, Barker C, Brayman KL.
    Transplant Proc; 1997 Dec 27; 29(8):3669-70. PubMed ID: 9414883
    [No Abstract] [Full Text] [Related]

  • 37. Mycophenolate mofetil in living donor renal allograft recipients.
    Park K, Moon JI, Kim SI, Kim YS.
    Transplant Proc; 1999 Dec 27; 31(1-2):1133. PubMed ID: 10083506
    [No Abstract] [Full Text] [Related]

  • 38. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ.
    Clin Transplant; 2007 Dec 27; 21(1):101-9. PubMed ID: 17302598
    [Abstract] [Full Text] [Related]

  • 39. Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols.
    Meier-Kriesche HU, Friedman G, Jacobs M, Mulgaonkar S, Vaghela M, Kaplan B.
    Transplantation; 1999 Nov 27; 68(10):1496-502. PubMed ID: 10589946
    [Abstract] [Full Text] [Related]

  • 40. Long-term experience with mycofenolate mofetil in the prevention of renal allograft rejection.
    Behrend M, Lueck R, Pichlmayr R.
    Transplant Proc; 1997 Nov 27; 29(7):2927-9. PubMed ID: 9365617
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.